CRK and pancreatic ductal adenocarcinoma: Jiao, et al. reported miR-126 down-regulation in pancreatic ductal adenocarcinoma, with elevations in KRAS and CRK, and confirmed that miR-126 directly inhibits KRAS translation via interaction with a KRAS 3′UTR “seedless” site [18].